Akt forms an intracellular complex with heat shock protein 90 (Hsp90) and Cdc37 and is destabilized by inhibitors of Hsp90 function

被引:540
|
作者
Basso, AD
Solit, DB
Chiosis, G
Giri, B
Tsichlis, P
Rosen, N
机构
[1] Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA
[3] Thomas Jefferson Univ, Kimmel Canc, Philadelphia, PA 19107 USA
[4] Cornell Univ, Weill Grad Sch Med Sci, Program Pharmacol, Philadelphia, PA 19107 USA
关键词
D O I
10.1074/jbc.M206322200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hsp90 is a chaperone required for the conformational maturation of certain signaling proteins including Raf, cdk4, and steroid receptors. Natural products and synthetic small molecules that bind to the ATP-binding pocket in the amino-terminal domain of Hsp90 inhibit its function and cause the degradation of these client proteins. Inhibition of Hsp90 function in cells causes down-regulation of an Akt kinase-dependent pathway required for D-cyclin expression and retinoblastoma protein-dependent G, arrest. Intracellular Akt is associated with Hsp90 and Cdc37 in a complex in which Akt kinase is active and regulated by phosphatidylinositol 3-kinase. Functional Hsp90 is required for the stability of Akt in the complex. Occupancy of the ATP-binding pocket by inhibitors is associated with the ubiquitination of Akt and its targeting to the proteasome, where it is degraded. This results in a shortening of the half-life of Akt from 36 to 12 h and an 80% reduction in its expression. Akt and its activating kinase, PDK1, are the only members of the protein kinase A/protein kinase B/protein kinase C-like kinase family that are affected by Hsp90 inhibitors. Thus, transduction of growth factor signaling via the Akt and Raf pathways requires functional Hsp90 and can be coordinately blocked by its inhibition.
引用
收藏
页码:39858 / 39866
页数:9
相关论文
共 50 条
  • [21] Interaction of cepharanthine with immobilized heat shock protein 90α (Hsp90α) and screening of Hsp90α inhibitors (vol 434, pg 202, 2013)
    Haginaka, Jun
    Kitabatake, Tomoko
    Hirose, Iyo
    Matsunaga, Hisami
    Moaddel, Ruin
    ANALYTICAL BIOCHEMISTRY, 2013, 436 (02) : 65 - 65
  • [22] Understanding conformational diversity of heat shock protein 90 (HSP90) and binding features of inhibitors to HSP90 via molecular dynamics simulations
    Yan, Fangfang
    Liu, Xinguo
    Zhang, Shaolong
    Zhang, Qinggang
    Chen, Jianzhong
    CHEMICAL BIOLOGY & DRUG DESIGN, 2020, 95 (01) : 87 - 103
  • [23] Advances in the clinical development of heat shock protein 90 (Hsp90) inhibitors in cancers
    Jhaveri, Komal
    Taldone, Tony
    Modi, Shanu
    Chiosis, Gabriela
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2012, 1823 (03): : 742 - 755
  • [24] Molecular modelling and docking studies on heat shock protein 90 (Hsp90) inhibitors
    Saxena, A. K.
    Saxena, S.
    Chaudhaery, S. S.
    SAR AND QSAR IN ENVIRONMENTAL RESEARCH, 2010, 21 (1-2) : 1 - 20
  • [25] Fused kinase is stabilized by Cdc37/Hsp90 and enhances Gli protein levels
    Kise, Yoshiaki
    Takenaka, Kei
    Tezuka, Tohru
    Yamamoto, Tadashi
    Miki, Hiroaki
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 351 (01) : 78 - 84
  • [26] Heat Shock Protein 90 (Hsp90) in Fungal Growth and Pathogenesis
    Lamoth F.
    Juvvadi P.R.
    Steinbach W.J.
    Current Fungal Infection Reports, 2014, 8 (4) : 296 - 301
  • [27] Role of Heat Shock Protein 90 (Hsp90) in Insulin Secretion
    Tamarina, Natalia A.
    Philipson, Louis H.
    DIABETES, 2013, 62 : A575 - A576
  • [28] Yeast is selectively hypersensitised to heat shock protein 90 (Hsp90)-targetting drugs with heterologous expression of the human Hsp90β, a property that can be exploited in screens for new Hsp90 chaperone inhibitors
    Piper, PW
    Panaretou, B
    Millson, SH
    Truman, A
    Mollapour, M
    Pearl, LH
    Prodromou, C
    GENE, 2003, 302 (1-2) : 165 - +
  • [29] Cdk2: A genuine protein kinase client of Hsp90 and Cdc37
    Prince, T
    Sun, L
    Matts, RL
    BIOCHEMISTRY, 2005, 44 (46) : 15287 - 15295
  • [30] Y-632 inhibits heat shock protein 90 (Hsp90) function by disrupting the interaction between Hsp90 and Hsp70/Hsp90 organizing protein, and exerts antitumor activity in vitro and in vivo
    Wang, Wenqian
    Liu, Yang
    Zhao, Zhixin
    Xie, Chengying
    Xu, Yongping
    Hu, Youhong
    Quan, Haitian
    Lou, Liguang
    CANCER SCIENCE, 2016, 107 (06) : 782 - 790